{"id":45935,"date":"2022-07-07T19:02:10","date_gmt":"2022-07-07T17:02:10","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\/"},"modified":"2022-07-07T19:02:10","modified_gmt":"2022-07-07T17:02:10","slug":"cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\/","title":{"rendered":"Cubresa Appoints Mr. Matt Hudson as Chief Financial Officer and Ms. Mayra Alejo as Director of Quality"},"content":{"rendered":"
\n

WINNIPEG, Manitoba–(BUSINESS WIRE)–#Cubresa<\/a>—Cubresa Inc<\/a>., a world leader in the design and development of PET insert systems for brain imaging, is announcing two new senior appointments: Mr. Matt Hudson as CFO and Ms. Mayra Alejo as Director of Quality.\n<\/p>\n

<\/a><\/p>\n

\n\u201cThe addition of Matt and Mayra to the leadership team are critical as Cubresa advances into the clinical marketplace,\u201d said James Schellenberg, Ph.D., Cubresa\u2019s Founder and CEO. \u201cThese new appointments strengthen our team and signify the company is well positioned as we expand into new markets and regions. We are pleased to welcome them to the Cubresa family.\u201d\n<\/p>\n

\nMr. Matt Hudson<\/b>\n<\/p>\n

\nMatt Hudson has over 15 years of financial and operational experience, primarily with high growth organizations. Prior to Joining Cubresa Matt was Vice President, Strategy and Transformation at People Corporation, one of the fastest growing companies in Canada. Previously he was a Senior Manager in Ernst & Young\u2019s Assurance and Advisory practices in Canada and Australia. Matt is a CPA, CA and holds a Bachelor of Commerce (Honours) from the University of Manitoba\n<\/p>\n

\nMs. Mariluz Alejo<\/b>\n<\/p>\n

\nMariluz (Mayra) Alejo is an experienced Senior Manager with over thirty years of progressive leadership advancement in pharmaceutical, natural health products, medical devices, and food industries. She has overseen fast-paced teams covering quality, regulatory, formulation, manufacturing, validation, engineering, and project management. She has direct experience with solid and liquid dosages, biologics, active pharmaceutical ingredients, and blood banking manufacturing and food environments.\n<\/p>\n

\nAbout Cubresa Inc.<\/b>\n<\/p>\n

\nCubresa, based in Winnipeg, Canada, is a world leader in the design and development of clinical PET inserts for MRI. Cubresa products are high-performance imaging solutions designed for advanced brain imaging and are being developed to enable researchers at leading universities, hospitals, and pharmaceutical companies to visualize and measure biochemical processes at the molecular level. www.cubresa.com<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nLisa Bako
\n
VP of Sales and Strategic Partnerships
\n
Cubresa Inc.
\n
+1 (204) 798-4579
\n
lbako@cubresa.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

WINNIPEG, Manitoba–(BUSINESS WIRE)–#Cubresa—Cubresa Inc., a world leader in the design and development of PET insert systems for brain imaging, is announcing two new senior appointments: Mr. Matt Hudson as CFO and Ms. Mayra Alejo as Director of Quality. \u201cThe addition of Matt and Mayra to the leadership team are critical as Cubresa advances into the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45935","6":"format-standard","7":"category-industry"},"yoast_head":"\nCubresa Appoints Mr. Matt Hudson as Chief Financial Officer and Ms. Mayra Alejo as Director of Quality - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cubresa Appoints Mr. Matt Hudson as Chief Financial Officer and Ms. Mayra Alejo as Director of Quality - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"WINNIPEG, Manitoba–(BUSINESS WIRE)–#Cubresa—Cubresa Inc., a world leader in the design and development of PET insert systems for brain imaging, is announcing two new senior appointments: Mr. Matt Hudson as CFO and Ms. Mayra Alejo as Director of Quality. \u201cThe addition of Matt and Mayra to the leadership team are critical as Cubresa advances into the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-07T17:02:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220707005590\/en\/1362117\/21\/cubresa_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Cubresa Appoints Mr. Matt Hudson as Chief Financial Officer and Ms. Mayra Alejo as Director of Quality\",\"datePublished\":\"2022-07-07T17:02:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\\\/\"},\"wordCount\":334,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220707005590\\\/en\\\/1362117\\\/21\\\/cubresa_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\\\/\",\"name\":\"Cubresa Appoints Mr. Matt Hudson as Chief Financial Officer and Ms. Mayra Alejo as Director of Quality - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220707005590\\\/en\\\/1362117\\\/21\\\/cubresa_logo.jpg\",\"datePublished\":\"2022-07-07T17:02:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220707005590\\\/en\\\/1362117\\\/21\\\/cubresa_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220707005590\\\/en\\\/1362117\\\/21\\\/cubresa_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cubresa Appoints Mr. Matt Hudson as Chief Financial Officer and Ms. Mayra Alejo as Director of Quality\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cubresa Appoints Mr. Matt Hudson as Chief Financial Officer and Ms. Mayra Alejo as Director of Quality - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\/","og_locale":"en_US","og_type":"article","og_title":"Cubresa Appoints Mr. Matt Hudson as Chief Financial Officer and Ms. Mayra Alejo as Director of Quality - Pharma Trend","og_description":"WINNIPEG, Manitoba–(BUSINESS WIRE)–#Cubresa—Cubresa Inc., a world leader in the design and development of PET insert systems for brain imaging, is announcing two new senior appointments: Mr. Matt Hudson as CFO and Ms. Mayra Alejo as Director of Quality. \u201cThe addition of Matt and Mayra to the leadership team are critical as Cubresa advances into the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-07T17:02:10+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220707005590\/en\/1362117\/21\/cubresa_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Cubresa Appoints Mr. Matt Hudson as Chief Financial Officer and Ms. Mayra Alejo as Director of Quality","datePublished":"2022-07-07T17:02:10+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\/"},"wordCount":334,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220707005590\/en\/1362117\/21\/cubresa_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\/","url":"https:\/\/pharma-trend.com\/en\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\/","name":"Cubresa Appoints Mr. Matt Hudson as Chief Financial Officer and Ms. Mayra Alejo as Director of Quality - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220707005590\/en\/1362117\/21\/cubresa_logo.jpg","datePublished":"2022-07-07T17:02:10+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220707005590\/en\/1362117\/21\/cubresa_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220707005590\/en\/1362117\/21\/cubresa_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/cubresa-appoints-mr-matt-hudson-as-chief-financial-officer-and-ms-mayra-alejo-as-director-of-quality\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Cubresa Appoints Mr. Matt Hudson as Chief Financial Officer and Ms. Mayra Alejo as Director of Quality"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45935","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45935"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45935\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45935"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45935"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45935"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}